Company news

BLS Pharmaceuticals Limited news in 2026

BLS Pharmaceuticals Limited's news releases, calls and decks from 2026, newest first.

View company

Directors Change of Interest Notice X 2

October 27, 2026

Application for quotation of securities - BLS

October 26, 2026

Letter to Shareholders re Annual General Meeting

October 23, 2026

Notice of Annual General Meeting/Proxy Form

October 23, 2026

Q1 FY2027 Quarterly Activities Update

October 20, 2026

Q1 FY2027 Quarterly Activities Update

October 20, 2026

BLS Quarterly Activities Report September 2026 Revised

October 14, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 14, 2026

Ceasing to be a substantial holder

October 12, 2026

Becoming a substantial holder

October 8, 2026

AGM Date and Director Nominations

October 6, 2026

Application for quotation of securities - BLS

October 4, 2026

Application for quotation of securities - BLS

September 28, 2026

Initial Director's Interest Notice

September 14, 2026

Angus Walker Appointed Alternate Director to Edward Myer

September 13, 2026

Application for quotation of securities - BLS

September 10, 2026

S&P DJI Announces September 2026 Quarterly Rebalance

September 4, 2026

Application for quotation of securities - BLS

September 4, 2026

Appendix 4G Corporate Governance Statement

August 31, 2026

BLS FY2027 Guidance

August 30, 2026

BLS Investor Presentation

August 30, 2026

BLS FY2026 Results Announcement

August 30, 2026

Annual Report to shareholders

August 30, 2026

BLS FY2026 Results Webinar 2 September 2026 8am AEST

August 26, 2026

Application for quotation of securities - BLS

August 12, 2026

BLS to Present at Coffee Microcaps 31/7/2026 at 11.30 am

July 30, 2026

BLS Pharmaceuticals Investor Webinar Presentation

July 29, 2026

BLS Q4 FY2026 Results Investor Webinar

July 29, 2026

Decks in 2026